Home Home Home Inbox Home Search

Event

PBI-4050 Therapy Selectively Improves Pulmonary Hypertension, Lung Remodeling and Right Ventricular Function in Heart Failure with Reduced Ejection Fraction [Board No. 1019]

Location: Board no. 1019
Session Type: Poster Discussion Session
Monday
May
21
2:15 PM
4:15 PM

Speaker(s)/Author(s)

Jean Claude. Tardif

MD, Ph.D.
Institut de Cardiologie de Montreal

Pierre Laurin

M.Sc.
Prometic Biosciences Inc.

Jocelyn Dupuis

MD, PhD
Institut de Cardiologie de Montreal

Angelo Calderone

Ph.D.
Institut de Cardiologie de Montreal

Alexandre Laverdure

B.Sc.
Prometic Biosciences Inc.

Lyne Gagnon

Ph.D.
Prometic Biosciences Inc.

Yanfen Shi

Ph.D.
Institut de Cardiologie de Montreal

Martin Sirois

Ph.D.
Institut de Cardiologie de Montreal

Brigitte Grouix

Ph.D.
Prometic Biosciences Inc.

Quang Trinh. Nguyen

Ph.D.
Institut de Cardiologie de Montreal

View Abstract

PBI-4050 Therapy Selectively Improves Pulmonary Hypertension, Lung Remodeling and Right Ventricular Function in Heart Failure with Reduced Ejection Fraction

Parent Sessions

  • B108 - PULMONARY HYPERTENSION: THE LATEST FINDINGS...
    05-21-2018 2:15 PM - 4:15 PM
    • Home Home Home Inbox Home Search